Literature DB >> 8246265

Insertion sequence IS200 can differentiate drug-resistant and drug-sensitive Salmonella typhi of Vi-phage types E1 and M1.

E J Threlfall1, E Torre, L R Ward, B Rowe, I Gibert.   

Abstract

The type strains of Vi-phage types E1, M1 and A of Salmonella typhi, together with drug-resistant and drug-sensitive strains of phage types E1 and M1 isolated in 1992 from patients associated with India or Pakistan, and a drug-resistant strain of phage type A isolated in South Africa in 1991, were characterised with respect to the presence of plasmids conferring resistance to antimicrobial drugs and their chromosomal insertion sequence IS200 profiles. The three type strains, the drug-sensitive strains of Vi-phage types E1 and M1, and a strain of phage type M1 resistant to ampicillin and trimethoprim but not to chloramphenicol, did not contain plasmids. In contrast, for strains of phage types E1 and M1 resistant to chloramphenicol, ampicillin and trimethoprim, and for the drug-resistant strain of phage type A, the complete spectrum of resistance was encoded by high molecular mass plasmids belonging to the H1 incompatibility group. Characterisation of IS200 profiles demonstrated that at least 13 IS200 copies were distributed on the chromosome of all strains tested. Although the IS200 profiles of the type strains of Vi-phage types A, E1 and M1 were identical, it was possible to distinguish between drug-sensitive and drug-resistant strains of Vi-phage types E1 and M1 isolated from patients infected in India and Pakistan by this method. It was concluded that although IS200 typing is not as discriminatory as phage typing for the primary subdivision of S. typhi, it may be useful for certain epidemiological investigations and, in particular, for investigating the origins of strains with multiple drug resistance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246265     DOI: 10.1099/00222615-39-6-454

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  8 in total

1.  Molecular typing reveals a unique clone of Salmonella enterica serotype typhi among Indian strains.

Authors:  Dinesh S Chandel; Rama Chaudhry; Aparajit B Dey; Pawan Malhotra
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Distinctive IS200 insertion between gyrA and rcsC genes in Salmonella typhi.

Authors:  E Calva; L G Ordoñez; M Fernandez-Mora; F J Santana; M Bobadilla; J L Puente
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

3.  Genome fingerprinting of Salmonella typhi by pulsed-field gel electrophoresis for subtyping common phage types.

Authors:  S Nair; C L Poh; Y S Lim; L Tay; K T Goh
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

4.  Single-nucleotide-polymorphism typing and genetic relationships of Salmonella enterica serovar Typhi isolates.

Authors:  Sophie Octavia; Ruiting Lan
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

5.  Insertion sequence IS200 fingerprinting of Salmonella typhi: an assessment of epidemiological applicability.

Authors:  E J Threlfall; E Torre; L R Ward; A Dávalos-Pérez; B Rowe; I Gibert
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

6.  Molecular typing of Salmonella enterica serovar typhi isolates from various countries in Asia by a multiplex PCR assay on variable-number tandem repeats.

Authors:  Yichun Liu; May-Ann Lee; Eng-Eong Ooi; Yeo Mavis; Ai-Ling Tan; Hung-Hiang Quek
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

7.  Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates.

Authors:  P W Hermans; S K Saha; W J van Leeuwen; H A Verbrugh; A van Belkum; W H Goessens
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

8.  Molecular fingerprinting of multidrug-resistant Salmonella enterica serotype Typhi.

Authors:  M D Hampton; L R Ward; B Rowe; E J Threlfall
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.